IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q1 2022 Holdings

Filed 2022-05-16 | 14 holdings | $103.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$48.2M1,047,44046.7%
Arvinas Inc(ARVN)COM04335A105$46.8M695,24745.4%
Argenx SE(ARGX)SPONSORED ADR04016X101$7.6M24,0007.3%
Spdr S&P Biotech ETF TR(XBI)CallUNIT78464A870$179.8K2,000,0000.2%
Spdr S&P 500 ETF TR(SPY)PutUNIT78462F103$158.1K350,0000.2%
Blueprint Medicines Corp(2L9)COM09627Y109$49.9K781,5390.0%
Spero Therapeutics Inc(SPRO)COM84833T103$45.9K5,281,5040.0%
Regenxbio Inc(RGNX)COM75901B107$37.1K1,118,6840.0%
Merus N VCOMN5749R100$33.4K1,261,5340.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$26.5K1,755,5060.0%
Uniqure NV(QURE)SHSN90064101$16.3K901,4900.0%
Amryt Pharma PLCSPONSORED ADS03217L106$13.6K1,640,0000.0%
Pieris Pharmaceuticals IncCOM720795103$11.2K3,708,8820.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$6.1K167,5000.0%